354 
HR 6 RFS 
(7) 15 million barrels of crude oil from the 
Strategic Petroleum Reserve during fiscal year 
2024; and 
(8) 15 million barrels of crude oil from the 
Strategic Petroleum Reserve during fiscal year 
2025. 
Amounts received for a sale under this subsection shall 
be deposited in the General Fund of the Treasury during 
the fiscal year in which the sale occurs. 
(b) EMERGENCY PROTECTION.—The Secretary shall 
not draw down and sell crude oil under this section in 
amounts that would result in a Strategic Petroleum Re-
serve that contains an inventory of petroleum products 
representing less than 90 days of emergency reserves, 
based on the average daily level of net imports of crude 
oil and petroleum products in the previous calendar year. 
(c) PROCEEDS.—Proceeds from a sale under this sec-
tion shall be deposited into the general fund of the Treas-
ury of the United States. 
Subtitle C—Miscellaneous 
SEC. 4061. LYME DISEASE AND OTHER TICK-BORNE DIS-
EASES. 
(a) IN GENERAL.—Title III of the Public Health 
Service Act (42 U.S.C. 241 et seq.) is amended by adding 
at the end the following new part: 
VerDate Sep 11 2014 
22:29 Jul 13, 2015
Jkt 049200
PO 00000
Frm 00354
Fmt 6652
Sfmt 6201
E:\BILLS\H6.RFS
H6
asabaliauskas on DSK5VPTVN1PROD with BILLS
355 
HR 6 RFS 
‘‘PART W—LYME DISEASE AND OTHER TICK- 
BORNE DISEASES 
‘‘SEC. 399OO. RESEARCH. 
‘‘(a) IN GENERAL.—The Secretary shall conduct or 
support epidemiological, basic, translational, and clinical 
research regarding Lyme disease and other tick-borne dis-
eases. 
‘‘(b) BIENNIAL REPORTS.—The Secretary shall en-
sure that each biennial report under section 403 includes 
information on actions undertaken by the National Insti-
tutes of Health to carry out subsection (a) with respect 
to Lyme disease and other tick-borne diseases, including 
an assessment of the progress made in improving the out-
comes of Lyme disease and such other tick-borne diseases. 
‘‘SEC. 399OO–1. WORKING GROUP. 
‘‘(a) ESTABLISHMENT.—The Secretary shall estab-
lish a permanent working group, to be known as the Inter-
agency Lyme and Tick-Borne Disease Working Group (in 
this section and section 399OO–2 referred to as the 
‘Working Group’), to review all efforts within the Depart-
ment of Health and Human Services concerning Lyme dis-
ease and other tick-borne diseases to ensure interagency 
coordination, minimize overlap, and examine research pri-
orities. 
‘‘(b) 
RESPONSIBILITIES.—The 
Working 
Group 
shall— 
VerDate Sep 11 2014 
22:29 Jul 13, 2015
Jkt 049200
PO 00000
Frm 00355
Fmt 6652
Sfmt 6201
E:\BILLS\H6.RFS
H6
asabaliauskas on DSK5VPTVN1PROD with BILLS
356 
HR 6 RFS 
‘‘(1) not later than 24 months after the date of 
enactment of this part, and every 24 months there-
after, develop or update a summary of— 
‘‘(A) ongoing Lyme disease and other tick- 
borne disease research related to causes, pre-
vention, 
treatment, 
surveillance, 
diagnosis, 
diagnostics, duration of illness, intervention, 
and access to services and supports for individ-
uals with Lyme disease or other tick-borne dis-
eases; 
‘‘(B) advances made pursuant to such re-
search; 
‘‘(C) the engagement of the Department of 
Health and Human Services with persons that 
participate at the public meetings required by 
paragraph (5); and 
‘‘(D) the comments received by the Work-
ing Group at such public meetings and the Sec-
retary’s response to such comments; 
‘‘(2) ensure that a broad spectrum of scientific 
viewpoints is represented in each such summary; 
‘‘(3) monitor Federal activities with respect to 
Lyme disease and other tick-borne diseases; 
VerDate Sep 11 2014 
22:29 Jul 13, 2015
Jkt 049200
PO 00000
Frm 00356
Fmt 6652
Sfmt 6201
E:\BILLS\H6.RFS
H6
asabaliauskas on DSK5VPTVN1PROD with BILLS
357 
HR 6 RFS 
‘‘(4) make recommendations to the Secretary 
regarding any appropriate changes to such activities; 
and 
‘‘(5) ensure public input by holding annual pub-
lic meetings that address scientific advances, re-
search questions, surveillance activities, and emerg-
ing strains in species of pathogenic organisms. 
‘‘(c) MEMBERSHIP.— 
‘‘(1) IN GENERAL.—The Working Group shall 
be composed of a total of 14 members as follows: 
‘‘(A) FEDERAL MEMBERS.—Seven Federal 
members, consisting of one or more representa-
tives of each of— 
‘‘(i) the Office of the Assistant Sec-
retary for Health; 
‘‘(ii) the Food and Drug Administra-
tion; 
‘‘(iii) the Centers for Disease Control 
and Prevention; 
‘‘(iv) 
the 
National 
Institutes 
of 
Health; and 
‘‘(v) such other agencies and offices of 
the Department of Health and Human 
Services as the Secretary determines ap-
propriate. 
VerDate Sep 11 2014 
22:29 Jul 13, 2015
Jkt 049200
PO 00000
Frm 00357
Fmt 6652
Sfmt 6201
E:\BILLS\H6.RFS
H6
asabaliauskas on DSK5VPTVN1PROD with BILLS
358 
HR 6 RFS 
‘‘(B) NON-FEDERAL PUBLIC MEMBERS.— 
Seven non-Federal public members, consisting 
of representatives of the following categories: 
‘‘(i) Physicians and other medical pro-
viders with experience in diagnosing and 
treating Lyme disease and other tick-borne 
diseases. 
‘‘(ii) Scientists or researchers with ex-
pertise. 
‘‘(iii) Patients and their family mem-
bers. 
‘‘(iv) Nonprofit organizations that ad-
vocate for patients with respect to Lyme 
disease and other tick-borne diseases. 
‘‘(v) Other individuals whose expertise 
is determined by the Secretary to be bene-
ficial to the functioning of the Working 
Group. 
‘‘(2) APPOINTMENT.—The members of the 
Working Group shall be appointed by the Secretary, 
except that of the non-Federal public members 
under paragraph (1)(B)— 
‘‘(A) one shall be appointed by the Speaker 
of the House of Representatives; and 
VerDate Sep 11 2014 
22:29 Jul 13, 2015
Jkt 049200
PO 00000
Frm 00358
Fmt 6652
Sfmt 6201
E:\BILLS\H6.RFS
H6
asabaliauskas on DSK5VPTVN1PROD with BILLS